53 related articles for article (PubMed ID: 28223668)
1. Genetic Counseling, Testing, and Management of HBOC in India: An Expert Consensus Document from Indian Society of Medical and Pediatric Oncology.
Malhotra H; Kowtal P; Mehra N; Pramank R; Sarin R; Rajkumar T; Gupta S; Bapna A; Bhattacharyya GS; Gupta S; Maheshwari A; Mannan AU; Reddy Kundur R; Sekhon R; Singhal M; Smruti BK; Sp S; Suryavanshi M; Verma A
JCO Glob Oncol; 2020 Jul; 6():991-1008. PubMed ID: 32628584
[TBL] [Abstract][Full Text] [Related]
2. The Genetic Paradigm of Hereditary Breast and Ovarian Cancer (HBOC) in the Afro-Caribbean Population.
Cerbon D; Taylor D; Barreto-Coelho P; Rodriguez E; Schlumbrecht M; Hurley J; George SHL
Crit Rev Oncog; 2024; 29(3):99-112. PubMed ID: 38683157
[TBL] [Abstract][Full Text] [Related]
3. Implementing mainstream genetic counseling within the area-wide network of the German Consortium Hereditary Breast and Ovarian Cancer (GC-HBOC): Satisfaction of primary care providers with the provided state-of-the-art training by the Cologne Center.
Herold N; Bredow K; Ernst C; Tüchler A; Blümcke B; Waha A; Keser E; Hauke J; Wappenschmidt B; Hahnen E; Schmutzler RK; Rhiem K
J Genet Couns; 2024 Feb; 33(1):206-215. PubMed ID: 38351721
[TBL] [Abstract][Full Text] [Related]
4. Young Women's Perspectives on Being Screened for Hereditary Breast and Ovarian Cancer Risk During Routine Primary Care.
Head M; Cohn B; Wernli KJ; Palazzo L; Ehrlich K; Matson A; Knerr S
Womens Health Issues; 2024; 34(3):268-275. PubMed ID: 38448251
[TBL] [Abstract][Full Text] [Related]
5. Promoting guideline-based cancer genetic risk assessment for hereditary breast and ovarian cancer in ethnically and geographically diverse cancer survivors: Rationale and design of a 3-arm randomized controlled trial.
Kinney AY; Howell R; Ruckman R; McDougall JA; Boyce TW; Vicuña B; Lee JH; Guest DD; Rycroft R; Valverde PA; Gallegos KM; Meisner A; Wiggins CL; Stroup A; Paddock LE; Walters ST
Contemp Clin Trials; 2018 Oct; 73():123-135. PubMed ID: 30236776
[TBL] [Abstract][Full Text] [Related]
6. EMQN best practice guidelines for genetic testing in hereditary breast and ovarian cancer.
McDevitt T; Durkie M; Arnold N; Burghel GJ; Butler S; Claes KBM; Logan P; Robinson R; Sheils K; Wolstenholme N; Hanson H; Turnbull C; Hume S
Eur J Hum Genet; 2024 May; 32(5):479-488. PubMed ID: 38443545
[TBL] [Abstract][Full Text] [Related]
7. Web-based return of BRCA2 research results: one-year genetic counselling experience in Iceland.
Stefansdottir V; Thorolfsdottir E; Hognason HB; Patch C; van El C; Hentze S; Cordier C; Mendes Á; Jonsson JJ
Eur J Hum Genet; 2020 Dec; 28(12):1656-1661. PubMed ID: 32523053
[TBL] [Abstract][Full Text] [Related]
8. Clients' experiences of empathy in genetic counseling for hereditary breast and ovarian cancer: A qualitative study in Japan.
Tomozawa C; Kaneko M; Sasaki M; Miyake H
J Genet Couns; 2024 May; ():. PubMed ID: 38773682
[TBL] [Abstract][Full Text] [Related]
9. National clinical Genetic Networks - GENets - Establishment of expert collaborations in Denmark.
Lildballe DL; Frederiksen AL; Schönewolf-Greulich B; Brasch-Andersen C; Lautrup CK; Karstensen HG; Pedersen IS; Sunde L; Risom L; Rasmussen M; Bertelsen M; Andersen MK; Rendtorff ND; Gregersen PA; Tørring PM; Hammer-Hansen S; Boonen SE; Lindquist SG; Hammer TB; Diness BR
Eur J Med Genet; 2023 Dec; 66(12):104872. PubMed ID: 37967791
[TBL] [Abstract][Full Text] [Related]
10. Current status of AYA-generation breast cancer: trends worldwide and in Japan.
Futamura M; Yoshida K
Int J Clin Oncol; 2022 Jan; 27(1):16-24. PubMed ID: 34921319
[TBL] [Abstract][Full Text] [Related]
11. Changes of Socio-demographic data of clients seeking genetic counseling for hereditary breast and ovarian cancer due to the "Angelina Jolie Effect".
Staudigl C; Pfeiler G; Hrauda K; Renz R; Berger A; Lichtenschopf R; Singer CF; Tea MK
BMC Cancer; 2016 Jul; 16():436. PubMed ID: 27391110
[TBL] [Abstract][Full Text] [Related]
12. Use of a Standardized Tool to Identify Women at Risk for Hereditary Breast and Ovarian.
Hessock M; Brewer T; Hutson S; Anderson J
Nurs Womens Health; 2021 Jun; 25(3):187-197. PubMed ID: 33933425
[TBL] [Abstract][Full Text] [Related]
13. Hereditary breast/ovarian cancer syndrome: a primer for obstetricians/gynecologists.
Meaney-Delman D; Bellcross CA
Obstet Gynecol Clin North Am; 2013 Sep; 40(3):475-512. PubMed ID: 24021253
[TBL] [Abstract][Full Text] [Related]
14. [Genetic Counseling of HBOC and Japanese Organization of HBOC].
Fukushima Y
Gan To Kagaku Ryoho; 2017 Feb; 44(2):107-110. PubMed ID: 28223668
[TBL] [Abstract][Full Text] [Related]
15. [Current clinical issues and recent trends in hereditary breast and ovarian cancer in Japan-genetic testing for HBOC and risk-reducing surgery].
Arai M; Iwase T; Takazawa Y; Takeshima N
Gan To Kagaku Ryoho; 2014 Nov; 41(11):1333-9. PubMed ID: 25434434
[TBL] [Abstract][Full Text] [Related]
16. Increasing referral of at-risk women for genetic counseling and BRCA testing using a screening tool in a community breast imaging center.
Arun BK; Peterson SK; Sweeney LE; Bluebond RD; Tidwell RSS; Makhnoon S; Kushwaha AC
Cancer; 2022 Jan; 128(1):94-102. PubMed ID: 34424535
[TBL] [Abstract][Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
